Kyowa Hakko obtains approval for EPO generic applied by injection

The “Darbepoetin alfa injection syringe” KKF contains Darbepoetin alfa, a sustained type erythropoiesis stimulating factor, and has been released as “Nesp®” in July 2007, then the main product of Kyowa Hakko Kirin.

Kyowa Kirin news release, August 16, 2018

 

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny